211 related articles for article (PubMed ID: 31173241)
1. Lidocaine inhibits the progression of retinoblastoma in vitro and in vivo by modulating the miR‑520a‑3p/EGFR axis.
Xia W; Wang L; Yu D; Mu X; Zhou X
Mol Med Rep; 2019 Aug; 20(2):1333-1342. PubMed ID: 31173241
[TBL] [Abstract][Full Text] [Related]
2. Lidocaine inhibits proliferation and induces apoptosis in colorectal cancer cells by upregulating mir-520a-3p and targeting EGFR.
Qu X; Yang L; Shi Q; Wang X; Wang D; Wu G
Pathol Res Pract; 2018 Dec; 214(12):1974-1979. PubMed ID: 30262429
[TBL] [Abstract][Full Text] [Related]
3. microRNA‑485 inhibits the malignant behaviors of retinoblastoma by directly targeting Wnt3a.
Lyu X; Wang L; Lu J; Zhang H; Wang L
Oncol Rep; 2019 May; 41(5):3137-3147. PubMed ID: 30896857
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of microRNA‑182 inhibits cell viability, invasion and angiogenesis in retinoblastoma through inhibition of the PI3K/AKT pathway and CADM2 upregulation.
Huang YX; Nie XG; Li GD; Fan DS; Song LL; Zhang XL
Int J Oncol; 2018 Dec; 53(6):2615-2626. PubMed ID: 30320366
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA SNHG14 promotes the aggressiveness of retinoblastoma by sponging microRNA‑124 and thereby upregulating STAT3.
Sun X; Shen H; Liu S; Gao J; Zhang S
Int J Mol Med; 2020 Jun; 45(6):1685-1696. PubMed ID: 32236565
[TBL] [Abstract][Full Text] [Related]
6. miR‑302c‑3p and miR‑520a‑3p suppress the proliferation of cervical carcinoma cells by targeting CXCL8.
Ding HM; Zhang H; Wang J; Zhou JH; Shen FR; Ji RN; Shi JY; Chen YG
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760117
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA‑98 suppresses cell growth and invasion of retinoblastoma via targeting the IGF1R/k‑Ras/Raf/MEK/ERK signaling pathway.
Guo L; Bai Y; Ji S; Ma H
Int J Oncol; 2019 Mar; 54(3):807-820. PubMed ID: 30664191
[TBL] [Abstract][Full Text] [Related]
8. Suppression of microRNA-125a-5p upregulates the TAZ-EGFR signaling pathway and promotes retinoblastoma proliferation.
Zhang Y; Xue C; Zhu X; Zhu X; Xian H; Huang Z
Cell Signal; 2016 Aug; 28(8):850-60. PubMed ID: 27094723
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of circular RNA hsa_circ_0001649 indicates poor prognosis for retinoblastoma and regulates cell proliferation and apoptosis via AKT/mTOR signaling pathway.
Xing L; Zhang L; Feng Y; Cui Z; Ding L
Biomed Pharmacother; 2018 Sep; 105():326-333. PubMed ID: 29864621
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA‑382 inhibits cell proliferation and invasion of retinoblastoma by targeting BDNF‑mediated PI3K/AKT signalling pathway.
Song D; Diao J; Yang Y; Chen Y
Mol Med Rep; 2017 Nov; 16(5):6428-6436. PubMed ID: 28901408
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA‑330 is downregulated in retinoblastoma and suppresses cell viability and invasion by directly targeting ROCK1.
Wang L; Wang L; Li L; Zhang H; Lyu X
Mol Med Rep; 2019 Oct; 20(4):3440-3447. PubMed ID: 31432120
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA‑936 inhibits the malignant phenotype of retinoblastoma by directly targeting HDAC9 and deactivating the PI3K/AKT pathway.
Xu L; Li W; Shi Q; Wang M; Li H; Yang X; Zhang J
Oncol Rep; 2020 Feb; 43(2):635-645. PubMed ID: 31922233
[TBL] [Abstract][Full Text] [Related]
13. miR-491-3p is Downregulated in Retinoblastoma and Inhibit Tumor Cells Growth and Metastasis by Targeting SNN.
Hu Y; Zhao M; Li L; Ding J; Gui YM; Wei TW
Biochem Genet; 2021 Apr; 59(2):453-474. PubMed ID: 33098307
[TBL] [Abstract][Full Text] [Related]
14. microRNA -378a-3p Restrains the Proliferation of Retinoblastoma Cells but Promotes Apoptosis of Retinoblastoma Cells via Inhibition of FOXG1.
Zhang C; Wu S
Invest Ophthalmol Vis Sci; 2020 May; 61(5):31. PubMed ID: 32428232
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA‑93‑5p promotes the progression of human retinoblastoma by regulating the PTEN/PI3K/AKT signaling pathway.
Cao Y; Xia F; Wang P; Gao M
Mol Med Rep; 2018 Dec; 18(6):5807-5814. PubMed ID: 30365088
[TBL] [Abstract][Full Text] [Related]
16. High-mobility group protein B1 silencing promotes susceptibility of retinoblastoma cells to chemotherapeutic drugs through downregulating nuclear factor-κB.
Chai Y; Xiao J; Zhang S; Du Y; Luo Z; Zhou X; Huang K
Int J Mol Med; 2018 Mar; 41(3):1651-1658. PubMed ID: 29328447
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of microRNA‑492 attenuates cell proliferation and invasion in retinoblastoma via directly targeting LATS2.
Sun Z; Zhang A; Zhang L
Mol Med Rep; 2019 Mar; 19(3):1965-1971. PubMed ID: 30592270
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of lncRNA PVT1 inhibits retinoblastoma progression by sponging miR-488-3p.
Wu XZ; Cui HP; Lv HJ; Feng L
Biomed Pharmacother; 2019 Apr; 112():108627. PubMed ID: 30797143
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA CCAT1 promotes human retinoblastoma SO-RB50 and Y79 cells through negative regulation of miR-218-5p.
Zhang H; Zhong J; Bian Z; Fang X; Peng Y; Hu Y
Biomed Pharmacother; 2017 Mar; 87():683-691. PubMed ID: 28088735
[TBL] [Abstract][Full Text] [Related]
20. Impact of RARα and miR-138 on retinoblastoma etoposide resistance.
Busch M; Miroschnikov N; Dankert JT; Wiesehöfer M; Metz K; Stephan H; Dünker N
Tumour Biol; 2021; 43(1):11-26. PubMed ID: 33935126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
